The linker component PLGLAG is predominantly sensitive to an enzyme called matrix metalloproteinase 2 (MMP-2), and this enzyme-sensitive substrate strategy was employed for tumor targeting of DOX (Shi et al., 2012; Torchilin 2014; Zhu et al., 2014). This evidence concerns the gene MMP2 and neoplasm.